Health & Fitness
Health & Fitness
India tightens watch on GLP-1 drugs amid safety and misuse concerns
New Delhi, April 4, 2026
India’s drug regulators are stepping up oversight of fast-growing weight-loss and diabetes therapies, particularly GLP-1 receptor agonists, amid rising demand...
Health & Fitness
UK Heart Rhythm Expert Now Performing Procedures In India
Chandigarh, April 3, 2026
Britain-based cardiologist and electrophysiologist Prof Dhiraj Gupta is currently on an Indian tour performing complex atrial fibrillation (AF) procedures while training...
Health & Fitness
Dr Reddy’s Labs to change drug name to ‘Olymra’ amid court scrutiny: Report
New Delhi, March 27, 2026
Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name...
Health & Fitness
Govt intensifies regulatory surveillance against GLP-1 based weight loss drugs
New Delhi, March 24, 2026
Amid serious concerns over recent introduction of multiple generic variants of GLP-1 based weight loss drugs in the Indian market,...
Health & Fitness
Indian pharma companies launch generic semaglutide injections for diabetes
New Delhi, March 21, 2026
Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for...
